You can email us at, or call us on 01202 539791.Email: Phone: 01202 539791.


Anlotinib Dihydrochloride

Anlotinib dihydrochloride is in phase II/III clinical trials for the treatment of metastatic colorectal cancer and advanced gastric adenocarcinoma. The compound was co-developed by CTTQ Pharmaceutical and Advenchen Laboratory.

Product Details

Category Cancer Research and Antivirals
Price POA
CAS Number 1360460-82-7
Formula C23H22FN3O3 • 2HCl
Molecular Weight 480.36
Purity 98.0%
Availability In Stock
Storage Conditions +4˚C

Product Enquiry

Send us your enquiry for Anlotinib Dihydrochloride. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.

We value your input so if you have suggestions regarding new applications for Anlotinib Dihydrochloride email us and we will include your contribution on the website.

Enquire about product

Back to Top